Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.4682
Nov 20 • 4:00 PM ET Dollar change-0.0318 Percentage change(-6.36%)
Aftermarket Close
0.4682
Aftermarket • 4:15 PM ET Dollar change0.0000 Percentage change(0.00%)
Index
-
Market Cap
2.10M
Enterprise Value
10.43M
Income
-8.85M
Sales
0.92M
Book/sh
-1.97
Cash/sh
0.07
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
5
IPO
Jul 12, 2023
P/E
-
Forward P/E
-
PEG
-
P/S
2.28
P/B
-
P/C
6.77
P/FCF
-
EV/EBITDA
-
EV/Sales
11.34
Quick Ratio
0.91
Current Ratio
1.17
Debt/Eq
0.25
LT Debt/Eq
0.18
Option/Short
No / Yes
EPS (ttm)
-4.29
EPS next Y
-
EPS next Q
-0.61
EPS this Y
73.06%
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
64.19% 37.74%
Sales past 3/5Y
40.21% -11.18%
EPS Y/Y TTM
85.37%
Sales Y/Y TTM
-32.09%
EPS Q/Q
71.62%
Sales Q/Q
-55.87%
Insider Own
24.84%
Insider Trans
0.66%
Inst Own
9.70%
Inst Trans
6.56%
ROA
-170.54%
ROE
-316.47%
ROIC
-843.68%
Gross Margin
25.16%
Oper. Margin
-958.15%
Profit Margin
-962.84%
SMA20
-32.55%
SMA50
-47.89%
SMA200
-69.46%
Trades
Shs Outstand
3.90M
Shs Float
3.37M
52W High
8.62 -94.57%
52W Low
0.46 1.76%
Volatility
11.00% 15.78%
ATR (14)
0.10
RSI (14)
30.13
Beta
2.72
Rel Volume
0.13
Avg Volume
401.38K
Volume
51,295
Perf Week
-9.60%
Perf Month
-46.55%
Perf Quarter
-56.65%
Perf Half Y
-68.36%
Perf YTD
-76.97%
Perf Year
-88.41%
Perf 3Y
-99.69%
Perf 5Y
-
Perf 10Y
-
Prev Close
0.50
Price
0.47
Change %
-6.36%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOW GEOFFREY SPresident and CEOJun 12 '26Buy1.387,35010,13124,131Jun 15 04:50 PM
DOW GEOFFREY SPresident and CEODec 15 '25Buy0.809,6707,75959,618Dec 16 05:41 PM
DOW GEOFFREY SPresident and CEODec 10 '25Buy0.959,3508,88646,335Dec 12 08:39 AM
DOW GEOFFREY SPresident and CEODec 11 '25Buy0.923,6133,31849,948Dec 12 08:39 AM
60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.
ChairmanDr. Geoffrey Stuart Dow Ph.D.
Chief Financial OfficerMr. Tyrone Miller
Chief Commercial OfficerMs. Kristen Landon
Chief Medical OfficerDr. Bryan Smith